Table 2.
Study | Selection (4 stars) | Comparability (2 stars) | Outcome (3 stars) | Total score | |||||
---|---|---|---|---|---|---|---|---|---|
Representativeness of the hypertensive cohort | Selection of the non-hypertensive cohort | Ascertainment of hypertension | Demonstration that outcome of interest was not present at start of study | Assessment of outcome | Was follow up long enough for outcomes to occur? | Adequacy of follow up of cohort | |||
Rini (a) | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
Szmit | ★ | ★ | ★ | ★ | ★★ | ★ | ★ | ★ | 9 |
Bono | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
Fujita | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
Eechoute | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
Rini (b) | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
Motzer | – | ★ | ★ | ★ | – | ★ | ★ | ★ | 6 |
Hong | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
Nakano | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
Fujita | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
Eto | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
Rini (c) | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
Zhang (a) | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
Kucharz | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
Izzedine | ★ | ★ | ★ | ★ | ★ | ★ | ★ | ★ | 8 |
Donskov | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
Zhang (b) | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
Goldstein | ★ | ★ | ★ | ★ | ★★ | ★ | ★ | ★ | 9 |
Miyake | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
Fukuda | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
Matias | ★ | ★ | ★ | ★ | – | ★ | ★ | ★ | 7 |
—: The data were not available in this study